Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT06283979

A Randomized Controlled Phase II Trial of STIMULAN VG vs Standard of Care (SoC) for the Treatment of Osteomyelitis Associated With Stage IV Pressure Ulcers.

Led by Biocomposites Ltd · Updated on 2026-05-06

60

Participants Needed

9

Research Sites

76 weeks

Total Duration

On this page

Sponsors

B

Biocomposites Ltd

Lead Sponsor

M

MCRA

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this trial is to assess the safety, tolerability and between-group effect size of STIMULAN VG (with debridement) and a course of systemic antibiotics to standard of care (debridement and systemic antibiotics only) for the treatment of osteomyelitis associated stage IV pressure ulcers.

CONDITIONS

Official Title

A Randomized Controlled Phase II Trial of STIMULAN VG vs Standard of Care (SoC) for the Treatment of Osteomyelitis Associated With Stage IV Pressure Ulcers.

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Have a Stage IV pressure ulcer needing excision, bony debridement, and flap coverage or primary closure
  • Be a candidate for flap surgery or primary closure
  • Have focal osteomyelitis shown by MRI or CT scan
  • Be 18 years of age or older at treatment
  • Be mentally, physically, and psychosocially able to follow the study plan
  • Provide voluntary signed informed consent before any study procedures
Not Eligible

You will not qualify if you...

  • Causes of the pressure ulcer cannot be addressed
  • Severely immunocompromised as determined by a clinician
  • Have diffuse or widespread pelvic osteomyelitis not suitable for adequate debridement
  • Have head pressure ulcers
  • History of active substance abuse in the last 2 years that may affect safety or recovery
  • Current smoker
  • Diabetic with Hba1C above 9
  • Allergy to any component of the investigational product like calcium sulfate or certain antibiotics
  • Currently in another investigational product study
  • Pregnant or planning pregnancy during the study
  • Flexion contractures preventing full passive extension
  • Uncontrolled muscle spasms
  • Unable to comply with bedrest or offloading requirements
  • Unable to provide consent
  • Fecal or urinary incontinence contaminating the wound
  • Lower extremity pressure ulcer with vascular compromise defined by specific index or pressure thresholds
  • Clinically malnourished as judged by investigator
  • Conditions with known or high risk for hypercalcemia
  • Investigator believes participation risks safety or trial results
  • Patients with vascularly compromised lower extremity ulcers may be rescreened after successful revascularization

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 9 locations

1

Advanced Foot Care, LLC

Phoenix, Arizona, United States, 85032

Actively Recruiting

2

Northwestern University Feinberg School of Medicine

Chicago, Illinois, United States, 60611

Actively Recruiting

3

Henry Ford Hospital

Detroit, Michigan, United States, 48202

Actively Recruiting

4

University of Mississippi Medical Center

Jackson, Mississippi, United States, 39216

Actively Recruiting

5

Missouri Orthopaedic Institute

Columbia, Missouri, United States, 65201

Actively Recruiting

6

University of Nebraska Medical Center

Omaha, Nebraska, United States, 68198

Actively Recruiting

7

Rutgers New Jersey Medical School

Newark, New Jersey, United States, 07103

Actively Recruiting

8

NYU Langone Hospital - Long Island Clinical Research Center

Mineola, New York, United States, 11501

Actively Recruiting

9

University of Pittsburgh, McGowan Institute for Regenerative Medicine

Pittsburgh, Pennsylvania, United States, 15219

Actively Recruiting

Loading map...

Research Team

K

Keira Watts, Clinical Research Director

CONTACT

D

Daniel Roberts

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Randomized Controlled Phase II Trial of STIMULAN VG vs Standard of Care (SoC) for the Treatment of Osteomyelitis Associated With Stage IV Pressure Ulcers. | DecenTrialz